COMMUNIQUÉS West-GlobeNewswire

The Ensign Group Reports First Quarter Results
02/05/2018
Conference Call and Webcast scheduled for tomorrow, May 3, 2018 at 10:00 am PT MISSION VIEJO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of [...]
Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR-T Therapy
02/05/2018
Lenzilumab effectively neutralizes GM-CSF CAR-T cells maintained robust anti-tumor activity in combination with lenzilumab GM-CSF depletion by lenzilumab may increase CAR-T expansion BRISBANE, Calif., May 02, 2018 ( [...]
Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab
02/05/2018
Holzkirchen, May 2, 2018 - Sandoz, a Novartis division, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics Licensing Application (BLA) for [...]
TRACON to Report First Quarter 2018 Company Highlights and Financial Results on May 9, 2018
02/05/2018
SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
miRagen Therapeutics Presents New Preclinical Data Supporting use of MicroRNA-Targeted Therapies for Ophthalmic Diseases
02/05/2018
Dosing with microRNA mimics of the microRNA-183/96/182 cluster led to functional improvement of photoreceptors and vision in retinal degeneration model MRG-201 dosing inhibited the expression of multiple factors [...]
Conformis Reports First Quarter 2018 Financial Results
02/05/2018
BILLERICA, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint [...]
Ovid Therapeutics to Present at Deutsche Bank’s 43rd Annual Health Care Conference on May 9, 2018
02/05/2018
NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today [...]
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018
02/05/2018
GAITHERSBURG, Md., May 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ) today announced it will report its first quarter 2018 financial and operating results following the close of U.S. financial markets on [...]
Recro Pharma Announces Commercial Team Additions
02/05/2018
MALVERN, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates
02/05/2018
SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ), a biotechnology company focused on the development of novel medicines to treat liver disease, today announced financial results [...]
GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
02/05/2018
CARLSBAD, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK ) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]
Pacific Biosciences of California, Inc. Announces First Quarter 2018 Financial Results
02/05/2018
MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) today announced financial results for its first quarter ended March 31, 2018. Total revenue for the first [...]
Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update
02/05/2018
The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3 The 20ug dose of G100 shows a two-fold increase in TILs, higher than that seen at the 10ug dose Conference call at 1:30 pm Pacific today [...]
Collegium to Present at the Deutsche Bank Health Care Conference
02/05/2018
CANTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that management will present at the Deutsche Bank 43 rd Annual Health Care Conference on Tuesday, May 8, [...]
Teladoc Announces Proposed Offering of $225 Million of Convertible Senior Notes due 2025
02/05/2018
PURCHASE, NY, May 02, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) today announced its intention to offer, subject to market conditions and other factors, $225 million aggregate principal amount of Convertible [...]
Aduro Biotech Reports First Quarter 2018 Financial Results
02/05/2018
BERKELEY, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today reported financial results for the first quarter ended March 31, 2018. Net loss for the first quarter of 2018 was $21.5 [...]
Nuvectra™ Reports First Quarter 2018 Financial Results
02/05/2018
PLANO, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2018. Highlights [...]
Trevena to Present at the Deutsche Bank 43rd Annual Healthcare Conference
02/05/2018
CHESTERBROOK, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Deutsche Bank 43 rd Annual Healthcare Conference on Tuesday, May 8 th , 2018, at 3:30 p [...]
Harvard Bioscience Reports First Quarter 2018 Financial Results
02/05/2018
-Reports GAAP and adjusted non-GAAP revenue of $26.8 million and $27.7 million, respectively, an increase of 48% and 15%, respectively- HOLLISTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq [...]

Pages